Monocyte chemoattractant protein-1 (MCP-1) g.-2518A>G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab

References

• Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, et al. 2009. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One 4:e5168
   PubMed Web of Science ®Google Scholar
• Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G, Narayanan PR. 2009. CCR2, MCP-1, SDF-1α & DC-sign gene polymorphisms in HIV-1infected patients with & without tuberculosis. Indian J Med Res 130:444–450
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2011. Standards of medical care in diabetes. Diabetes Care 34:1
   Web of Science ®Google Scholar
• Anjana RM, Ali MK, Pradeepa R, Deepa M, Datta M, Unnikrishnan R, Rema M, Mohan V. 2011. The need for obtaining accurate nationwide estimates of diabetes prevalence in India – Rationale for a national study on diabetes. Indian J Med Res 133:369–380
   PubMed Web of Science ®Google Scholar
• Arnold F, Parasuraman S, Arokiasamy P, Kothari M. 2009. Nutrition in India. National Family Health Survey (NFHS-3), India, 2005-06. Mumbai: International Institute for Population Sciences; Calverton, MD: ICF Macro. Available online at: http://www.nfhsindia.org/nfhs3.pdf (accessed December 7, 2013)
   Google Scholar
• Ayodele OE, Alebiosu CO, Salako BL. 2004. Diabetic nephropathy: a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 96:1445–1454
   PubMed Web of Science ®Google Scholar
• Banba N, Nakamura T, Matsumura M, Kurodo H, Hattori Y, Kasai K. 2000. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58:684–690
   PubMed Web of Science ®Google Scholar
• Bucova M, Jan L, Penz P, Mrazek F, Petrkova J, Bernadic M, Petrek M. 2009. Association of MCP-1-2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension. Mediat Inflamm 2009:390951. doi:10.1155/2009/390951
   Google Scholar
• Gluhovschi GH, Gluhovschi A, Anastasiu D, Petrica L, Gluhovschi C, Velciov S. 2012. Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. Rom J Intern Med 50:135–144
   PubMedGoogle Scholar
• Hassan AM, Nagy H, Mohamed WWS. 2010. Circulating MCP-1 level and 2518 gene polymorphism as a marker of nephropathy development in Egyptian patients. Egypt J Med Hum Genet 11:159–166
   Google Scholar
• International Diabetes Federation. 2011. IDF diabetes Atalas. 5th ed. Brussels: Internatinal Diabetes Federation
   Google Scholar
• Jeon HJ, Choi HJ, Park BH, Lee YH, Taekeun OH. 2013. Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes. Yonsei Med J 54:621–625
   PubMed Web of Science ®Google Scholar
• Jing Y, Zhu D, Bi Y, Yang D, Hu Y, Shen S. 2011. Monocyte chemoattractant protein 1 -2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population. Clin Chim Acta 412:466–469
   PubMed Web of Science ®Google Scholar
• Joo KW, Hwang YH, Kim JH, Oh KH, Kim H, Shin HD, Chung WK, et al. 2007. MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease. J Korean Med 22:611–615
   PubMed Web of Science ®Google Scholar
• Karadeniz M, Erdogan M, Cetinkalp S, Berdeli A, Eroglu Z, Ozgen AG. 2010. Monocyte chemoattractant protein 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy. Endocronology 37:513–517
   Google Scholar
• Kaur R, Matharoo K, Arora P, Bhanwer AJS. 2013. Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease. GTMB 17:750–755
   Google Scholar
• Kruger B, Schroppel B, Ashkan R, Marder B, Zulke C, Murphy B, Kramer BK, Fischereder M. 2002. A Monocyte Chemoattractant Protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 13:2585–2589
   PubMed Web of Science ®Google Scholar
• Levey AS, De Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, et al. 2011. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kid Int 80:17–28
   PubMed Web of Science ®Google Scholar
• Mani MK. 1998. Patterns of renal disease in indigenous population in India. Nephrology 14:s4–s7
   Web of Science ®Google Scholar
• Matharoo K, Arora P, Bhanwer AJ. 2013. Association of Adiponectin (ADIPOQ) and sulphonylurea receptor (ABCC8) gene polymorphism with Type 2 Diabetes in North Indian population of Punjab. Gene 527:228–234
   PubMed Web of Science ®Google Scholar
• Melgarejo E, Medinaa MA, Sanchez-Jimeneza F, Urdiales JL. 2009. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell B 41:998–1001
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
   PubMed Web of Science ®Google Scholar
• Modi GK, Jha V. 2006. The incidence of end stage renal disease in India, a population based study. Kidney Int 70:2131–2133
   PubMed Web of Science ®Google Scholar
• Mohan V, Shah S, Saboo B. 2013. Current Glycemic status and diabetes related complications among Type 2 Diabetes patients in India: data from the A1chieve study. J Assoc Physicians India 61:12–15
   PubMedGoogle Scholar
• Moon JY, Jeong L, Lee S, Jeong K, Lee T, Ihm CG. 2007. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 22:810–814
   PubMed Web of Science ®Google Scholar
• Morii T, Fujita H, Narita T, Shimotomai T, Fujishima H, Yoshioka N. 2003. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J Diabetes Complicat 17:11–15
   PubMed Web of Science ®Google Scholar
• Olugbenga EA, Alebiosu CO, Salako BL. 2004. Diabetic nephropathy a review of the nature, history, burden, risk factors and treatment. J Natl Med Assoc 96:1445–1454
   PubMed Web of Science ®Google Scholar
• Pickup JC. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823
   PubMed Web of Science ®Google Scholar
• Rovin BH, Lu L, Saxena R. 1999. A novel polymorphism in the MCP-1gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344–348
   PubMed Web of Science ®Google Scholar
• Sakhuja V, Sud K. 2003. End stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int 63:115–S118
   Web of Science ®Google Scholar
• Seliger SL, Davis C, Stehman-Breen C. 2001. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10:219–225
   PubMed Web of Science ®Google Scholar
• Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO. 2004. Association between the A 2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 47:1574–1580
   PubMed Web of Science ®Google Scholar
• Singh IP, Bhasin MK. 1968. Anthropometry. Delhi: Kamla Raj Enterprises
   Google Scholar
• Tesch GH. 2008. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294:697–701
   PubMed Web of Science ®Google Scholar
• Vivante A, Golan E, Tzur D, Leiba A, Tirosh K, Skorecki K, Calderon-Margalit R. 2012. Body Mass Index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med 172:1644–1650
   Google Scholar
• Weiner JS, Laurie JA. 1981. Practical human biology. London: Academic Press
   Google Scholar
• Yadav N, Rawat P, John A, Javery S, Swapnil N, Dharmappa B, Padmamohanan. 2012. Physical health related quality of life of end stage renal disease patients undergoing dialysis. Int J Basic Appl Med Sci 2:158–163
   Google Scholar
• Yadav A, Saini V, Arora S. 2010. MCP-1: Chemoattractant with a role beyond immunity. Clin Chim Acta 411:1570–1579
   PubMed Web of Science ®Google Scholar
• Yanes LL, Sartori-Valinotti JC, Reckelhoff JF. 2008. Sex steroids and renal disease lessons from animal studies. Hypertension 51:976–981
   PubMed Web of Science ®Google Scholar